Before delivering his address during ACR Convergence 2020, Anthony S. Fauci, MD, was awarded the ACR Distinguished Global Public Health Award during the special session COVID-19: Public Health and Scientific Challenges.

With Phase 2 of the Accelerating Medicines Partnership (AMP) study of systemic lupus erythematosus (SLE) underway, an ACR Convergence 2020 session featured a panel that reviewed the methods being used […]

Cardiovascular disease is the dominant cause of mortality in myositis patients, accounting for up to 55% of deaths.

Effective disease self-management for patients requires a patient-provider partnership, and an educational session at ACR Convergence 2020 offered practical steps for providers to encourage lupus patients to succeed at self-management.

NBC News medical contributor Natalie Azar, MD, will interview Annual Meeting Planning Committee Basic Science and Clinical Chairs Gregg Silverman, MD, and Diane Kamen, MD, MSCR.

As use of immune checkpoint inhibitors increases, so does the number of patients experiencing rheumatologic immune-related adverse events.

Checkpoint inhibitors have revolutionized the care of patients with certain cancers; however, patients treated with these therapies often develop immune-related adverse events that strongly resemble rheumatic autoimmune diseases.

Imaging plays a critical role in axial spondyloarthritis (axSpA) diagnosis, and three speakers will try to bring greater clarity to imaging issues during Controversies in the Diagnostic Evaluation of Axial Spondyloarthritis: An Experiential Review.